Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women

Maria Luz Fernandez, Shiva Metghalchi, Sonia Vega-Lopez, Karin Conde-Knape, Timothy G. Lohman, Zaida R. Cordero-Macintyre

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A total of 39 postmenopausal women 40-70 years of age and undergoing hormone replacement therapy participated in a 6-month weight reduction program, which consisted of a low calorie diet (5040 KJ/day) and phentermine hydrochloride therapy. Subjects had an average body mass index of 35.95±5.32 kg/m 2 and 42.20±11.0 kg of total fat. Body mass index, plasma lipids, total and trunk fat, and plasma apoproteins were measured at baseline and after 3 and 6 months of the weight reduction program. Subjects experienced an overall 10% weight loss during the treatment period (P<0.001). Plasma LDL cholesterol and triglycerides were reduced by 18% and 15% (P<0.01) respectively, whereas HDL cholesterol was increased by 9% (P<0.01) over the 6-month period. Plasma apoproteins were significantly affected by weight loss. Plasma apolipoprotein (apo) B concentrations were reduced 6.5% (P<0.01), and apo C-III and apo E were reduced by 9% over 6 months (P<0.01). The observed decreases in plasma apo B were significantly correlated with the observed changes in plasma cholesterol (r=0.356, P<0.01) over 3 months. In addition, changes in plasma triglycerides were correlated with changes in both apo C-III (r=0.436) and apo E (r=0.354) over 6 months. These results suggest that weight loss may have multifactorial effects on lipoprotein metabolism, resulting in better plasma lipid and apoprotein profiles.

Original languageEnglish (US)
Pages (from-to)717-721
Number of pages5
JournalJournal of Nutritional Biochemistry
Volume15
Issue number12
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Apolipoproteins
Weight Loss
Plasmas
Apoproteins
Apolipoprotein C-III
Weight Reduction Programs
Apolipoproteins B
Apolipoproteins E
Body Mass Index
Phentermine
Fats
Lipids
Caloric Restriction
Hormone Replacement Therapy
Metabolism
LDL Cholesterol
HDL Cholesterol
Lipoproteins
Triglycerides
Cholesterol

Keywords

  • Apolipoprotein B
  • Apolipoprotein C-III
  • Apolipoprotein E
  • Weight loss

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Fernandez, M. L., Metghalchi, S., Vega-Lopez, S., Conde-Knape, K., Lohman, T. G., & Cordero-Macintyre, Z. R. (2004). Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women. Journal of Nutritional Biochemistry, 15(12), 717-721. https://doi.org/10.1016/j.jnutbio.2004.07.001

Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women. / Fernandez, Maria Luz; Metghalchi, Shiva; Vega-Lopez, Sonia; Conde-Knape, Karin; Lohman, Timothy G.; Cordero-Macintyre, Zaida R.

In: Journal of Nutritional Biochemistry, Vol. 15, No. 12, 12.2004, p. 717-721.

Research output: Contribution to journalArticle

Fernandez, ML, Metghalchi, S, Vega-Lopez, S, Conde-Knape, K, Lohman, TG & Cordero-Macintyre, ZR 2004, 'Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women', Journal of Nutritional Biochemistry, vol. 15, no. 12, pp. 717-721. https://doi.org/10.1016/j.jnutbio.2004.07.001
Fernandez, Maria Luz ; Metghalchi, Shiva ; Vega-Lopez, Sonia ; Conde-Knape, Karin ; Lohman, Timothy G. ; Cordero-Macintyre, Zaida R. / Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women. In: Journal of Nutritional Biochemistry. 2004 ; Vol. 15, No. 12. pp. 717-721.
@article{87bad5eae601432ebcf17afb190d2418,
title = "Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women",
abstract = "A total of 39 postmenopausal women 40-70 years of age and undergoing hormone replacement therapy participated in a 6-month weight reduction program, which consisted of a low calorie diet (5040 KJ/day) and phentermine hydrochloride therapy. Subjects had an average body mass index of 35.95±5.32 kg/m 2 and 42.20±11.0 kg of total fat. Body mass index, plasma lipids, total and trunk fat, and plasma apoproteins were measured at baseline and after 3 and 6 months of the weight reduction program. Subjects experienced an overall 10{\%} weight loss during the treatment period (P<0.001). Plasma LDL cholesterol and triglycerides were reduced by 18{\%} and 15{\%} (P<0.01) respectively, whereas HDL cholesterol was increased by 9{\%} (P<0.01) over the 6-month period. Plasma apoproteins were significantly affected by weight loss. Plasma apolipoprotein (apo) B concentrations were reduced 6.5{\%} (P<0.01), and apo C-III and apo E were reduced by 9{\%} over 6 months (P<0.01). The observed decreases in plasma apo B were significantly correlated with the observed changes in plasma cholesterol (r=0.356, P<0.01) over 3 months. In addition, changes in plasma triglycerides were correlated with changes in both apo C-III (r=0.436) and apo E (r=0.354) over 6 months. These results suggest that weight loss may have multifactorial effects on lipoprotein metabolism, resulting in better plasma lipid and apoprotein profiles.",
keywords = "Apolipoprotein B, Apolipoprotein C-III, Apolipoprotein E, Weight loss",
author = "Fernandez, {Maria Luz} and Shiva Metghalchi and Sonia Vega-Lopez and Karin Conde-Knape and Lohman, {Timothy G.} and Cordero-Macintyre, {Zaida R.}",
year = "2004",
month = "12",
doi = "10.1016/j.jnutbio.2004.07.001",
language = "English (US)",
volume = "15",
pages = "717--721",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women

AU - Fernandez, Maria Luz

AU - Metghalchi, Shiva

AU - Vega-Lopez, Sonia

AU - Conde-Knape, Karin

AU - Lohman, Timothy G.

AU - Cordero-Macintyre, Zaida R.

PY - 2004/12

Y1 - 2004/12

N2 - A total of 39 postmenopausal women 40-70 years of age and undergoing hormone replacement therapy participated in a 6-month weight reduction program, which consisted of a low calorie diet (5040 KJ/day) and phentermine hydrochloride therapy. Subjects had an average body mass index of 35.95±5.32 kg/m 2 and 42.20±11.0 kg of total fat. Body mass index, plasma lipids, total and trunk fat, and plasma apoproteins were measured at baseline and after 3 and 6 months of the weight reduction program. Subjects experienced an overall 10% weight loss during the treatment period (P<0.001). Plasma LDL cholesterol and triglycerides were reduced by 18% and 15% (P<0.01) respectively, whereas HDL cholesterol was increased by 9% (P<0.01) over the 6-month period. Plasma apoproteins were significantly affected by weight loss. Plasma apolipoprotein (apo) B concentrations were reduced 6.5% (P<0.01), and apo C-III and apo E were reduced by 9% over 6 months (P<0.01). The observed decreases in plasma apo B were significantly correlated with the observed changes in plasma cholesterol (r=0.356, P<0.01) over 3 months. In addition, changes in plasma triglycerides were correlated with changes in both apo C-III (r=0.436) and apo E (r=0.354) over 6 months. These results suggest that weight loss may have multifactorial effects on lipoprotein metabolism, resulting in better plasma lipid and apoprotein profiles.

AB - A total of 39 postmenopausal women 40-70 years of age and undergoing hormone replacement therapy participated in a 6-month weight reduction program, which consisted of a low calorie diet (5040 KJ/day) and phentermine hydrochloride therapy. Subjects had an average body mass index of 35.95±5.32 kg/m 2 and 42.20±11.0 kg of total fat. Body mass index, plasma lipids, total and trunk fat, and plasma apoproteins were measured at baseline and after 3 and 6 months of the weight reduction program. Subjects experienced an overall 10% weight loss during the treatment period (P<0.001). Plasma LDL cholesterol and triglycerides were reduced by 18% and 15% (P<0.01) respectively, whereas HDL cholesterol was increased by 9% (P<0.01) over the 6-month period. Plasma apoproteins were significantly affected by weight loss. Plasma apolipoprotein (apo) B concentrations were reduced 6.5% (P<0.01), and apo C-III and apo E were reduced by 9% over 6 months (P<0.01). The observed decreases in plasma apo B were significantly correlated with the observed changes in plasma cholesterol (r=0.356, P<0.01) over 3 months. In addition, changes in plasma triglycerides were correlated with changes in both apo C-III (r=0.436) and apo E (r=0.354) over 6 months. These results suggest that weight loss may have multifactorial effects on lipoprotein metabolism, resulting in better plasma lipid and apoprotein profiles.

KW - Apolipoprotein B

KW - Apolipoprotein C-III

KW - Apolipoprotein E

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=10944248533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10944248533&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2004.07.001

DO - 10.1016/j.jnutbio.2004.07.001

M3 - Article

VL - 15

SP - 717

EP - 721

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 12

ER -